tert-Butyl 1-methyl-4-oxocyclohexanecarboxylate, 98%, 250mg

5-(Benzyloxy)-2-chloropyridine, 97%, 1g

3'-Methoxy-2,2,2-trifluoroacetophenone, 97.0%, 25g

4-(N-Boc-Aminomethyl)aniline, 98.0%, 1g

(S)-4-(tert-Butyl)-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole, 95.0%, 10g

ethyl 3-{[2-(morpholin-4-yl)ethyl]amino}propanoate, 95.0%, 2g

4-Oxo-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-5-carbaldehyde, 90.0%, 1g

Lucitanib, 98.94%, 10mg

1-Benzyl-3-methyl-pyrrolidine-3-carboxylic acid ethyl ester, 98%, 250mg

[(4-fluorophenyl)amino](oxo)acetic acid, 95.0%, 10g

tert-Butyl ((S)-1-((2S,4R)-4-hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate, 98%, 1g

Dispensers FORTUNA® OPTIFIX® Basic, 60-300 ml, 1 Piece

Copper(II) oxide, ROTI®nanoMETIC, min. 99%, 15-50 nm, 10 g, glass packaging